Why Traditional Planning Approaches Are Starting to Break Down
Pharmaceutical manufacturing has always been complex — but today, that complexity is accelerating.
More products, stricter compliance, tighter timelines, and increasing pressure on planning teams mean that traditional approaches are starting to show their limits.
For many organisations, planning is still supported by spreadsheets, ERP systems, or manual processes that were never designed to handle real-world production constraints.
The result?
Reactive planning. Limited visibility. And growing operational risk.

Across pharmaceutical organisations, we consistently see the same challenges:
- Difficulty managing multiple constraints (equipment, labour, sequencing)
- Limited visibility across stock, WIP, and capacity
- Poor responsiveness to disruption
- Heavy reliance on manual planning or Excel
- High inventory used as a safety buffer
These approaches may have worked in the past — but they struggle to keep up with modern manufacturing demands.
What Happens When Planning Evolves?
Forward-thinking pharmaceutical manufacturers are moving towards Siemens Opcenter APS to address these challenges.
Instead of reacting to issues, Opcenter APS enables teams to:
- Model real-world constraints
- Simulate different production scenarios
- Optimise schedules based on multiple variables
- Improve decision-making with better visibility
But what does that actually look like in practice?
Real-World Examples from Pharmaceutical Manufacturers
Drug Manufacturer – Brazil
This pattern continues in highly constrained environments. A pharmaceutical manufacturer in Brazil, previously reliant on high inventory levels to maintain service, used advanced scheduling to significantly improve performance. Service levels increased from 78% to 94%, raw material inventory was reduced by 80%, and setup times decreased by 30% — marking a clear shift from reactive planning to controlled, optimised operations.
UK Biopharmaceutical Manufacturer
A UK-based biopharmaceutical manufacturer producing biopharmaceutical products initially attempted to manage operations using project management tools. However, these tools could not handle the complexity of shift rotations and multiple operating groups. By introducing advanced scheduling, the organisation gained real-time production outcomes before execution, improved visibility of labour and equipment constraints, and increased confidence in scheduling decisions — As one user put it: “It can think — and work out the best way to get the jobs done.”
Healthcare Manufacturer – Netherlands
A similar challenge was faced by a healthcare manufacturer in the Netherlands, where an outdated scheduling system needed to be replaced and integrated with Microsoft Dynamics NAV. With the introduction of advanced scheduling, the organisation achieved greater visibility of tasks and work-in-progress, improved understanding of production costs, and the ability to run “what-if” scenarios to test decisions before committing — supporting more informed and proactive planning.
Pharmaceutical Laboratory – Argentina
As complexity increased further, a pharmaceutical laboratory in Argentina operating across hundreds of resources and tens of thousands of production operations found that manual planning could no longer keep pace. With continuous production and parallel QA processes, advanced scheduling became a key driver of operational improvement, delivering greater visibility across production and strengthening coordination between logistics and manufacturing.
The Measurable Impact of Better Planning
Across these examples, the benefits are consistent.
Organisations gain greater confidence in decision-making, supported by faster and more efficient planning processes. Service levels improve, delivery performance becomes more reliable, and inventory levels are reduced — helping to minimise both cost and waste. At the same time, teams are better equipped to respond to disruption, maintaining control even as conditions change.

But the impact goes beyond operational metrics.
Planning teams also gain something just as valuable — time.
Time to analyse.
Time to improve.
Time to make better decisions.
Why Does This Matters Now?
For pharmaceutical manufacturers, planning is no longer just operational — it’s strategic.
The ability to see further, respond faster, and act with confidence directly impacts:
- Service performance
- Cost control
- Risk management
- Operational stability
And increasingly, it defines competitive advantage.

For pharmaceutical manufacturers, planning is no longer just operational — it’s strategic.
The ability to see further, respond faster, and act with confidence directly impacts:
- Service performance
- Cost control
- Risk management
- Operational stability
And increasingly, it defines competitive advantage.
Ready to Take the Next Step?
If your planning processes are becoming harder to manage — or harder to trust — it may be time to rethink your approach.
📩 Speak to Steve Ward at steve.ward@kudossolutions.co.uk
Or connect with the team to explore what smarter scheduling could look like in your operation.







